Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07270185 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Measuring Outcomes With Validated Exercise

Study acronym: MOVE
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 5 more changesShow less
    • Final enrollment: 42 participants (planned 54)
    • Primary completion date changed from estimate of Dec 2026 to May 4, 2026
    • Eligibility criteria expanded, about 24 words
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site details revised
  2. Start date changed from estimate of Dec 2025 to Dec 4, 2025v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Physical activity and its intensity level is a critical determinant of health. Digital Health Technologies, such as wearable accelerometers (wrist-worn watch-like devices), can provide researchers and clinicians with objective measures of activity intensity, duration, and effect on an individual's physiology which can provide important insight into overall health. The purpose of this observational study is to assess how well wrist-worn devices can measure the intensity of movement and exercise. This study is designed to rigorously validate existing activity classification algorithms using synchronized multi-sensor data and indirect calorimetry during structured, semi-structured, and free-living tasks.
Trial Details
NCT Number NCT07270185
Lead Sponsor Boston University
Collaborators: Pfizer
Conditions
(from sponsor)		 Physical Activity
Related terms Motor Activity
Enrollment 42 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov